April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Inter-eye correlation in clinical measures of visual function in cone-rod dystrophy (CRD) patients
Author Affiliations & Notes
  • Benedetto Falsini
    Ophthalmology, Catholic University, Rome, Italy
  • Lucia Galli-Resta
    Istituto di Neuroscienze, Consiglio Nazionale delle Ricerche, Pisa, Italy
  • Marco Piccardi
    Ophthalmology, Catholic University, Rome, Italy
  • Lucia Ziccardi
    Ophthalmology, Bietti Foundation IRCCS, Roma, Italy
  • Antonello Fadda
    Tecnologie e Salute, Istituto Superiore di Sanita, Rome, Italy
  • Angelo Maria Minnella
    Ophthalmology, Catholic University, Rome, Italy
  • Dario Marangoni
    Ophthalmology, Catholic University, Rome, Italy
  • Giorgio Placidi
    Ophthalmology, Catholic University, Rome, Italy
  • Giovanni Resta
    Istituto di Informatica e Telematica, Consiglio Nazionale delle Ricerche, Pisa, Italy
  • Footnotes
    Commercial Relationships Benedetto Falsini, None; Lucia Galli-Resta, None; Marco Piccardi, None; Lucia Ziccardi, None; Antonello Fadda, None; Angelo Minnella, None; Dario Marangoni, None; Giorgio Placidi, None; Giovanni Resta, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1418. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benedetto Falsini, Lucia Galli-Resta, Marco Piccardi, Lucia Ziccardi, Antonello Fadda, Angelo Maria Minnella, Dario Marangoni, Giorgio Placidi, Giovanni Resta; Inter-eye correlation in clinical measures of visual function in cone-rod dystrophy (CRD) patients. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1418. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate inter-eye correlation in clinical measures of visual function in cone-rod dystrophy (CRD) patients and therefore the feasibility of clinical trial designs using monocular treatments and the untreated eye as an internal control

Methods: A retrospective study of the CRD patient database from the Ophthalmology Dept. of the Cattolic University in Rome. Baseline values were from 158 CRD patients. Follow-up measures from a subset of 46 CRD patients followed for 6.5 ± 3.2 years (2.5-13 years), with an average of 1 visit/year, and a minimum of 3 visits. Baseline age was 27± 16 years (9-67 years). Measures considered were: 1) best corrected visual acuity (BCVA, evaluated as minimal angle of resolution or MAR); 2) focal macular cone ERG (fERG) recorded in response to an 18 deg red central red field flickering at 41 Hz. This latter measure was chosen because it can detect early visual function decline in CRD, often anticipating BCVA loss of several years1

Results: Inter-eye correlation at baseline was very high for both BCVA and fERG (Spearman coefficient 0,858 N=123, P<10-35 for BCVA; 0.819, N=158; P<10-7 for fERG). In the follow-up cohort stationary patients had stationary visual measures in both eyes (N= 23 ; stationary cutoffs: fERG: -35% - +56%; BCVA: ±20%MAR), while progressive patients experienced BCVA and fERG decay in both eyes (N=23). Global linear fitting of logfERG showed that fERG progression rate was consistent between the 2 eyes. Yearly fERG loss in fast progressing patients: OD 35,7% (95%CI: 26,9-43.4% N=10 pz, Adj R20,76); OS 33,7% (95%CI: 25,5-41.0% N=10 pz, Adj R2 0,81). Yearly fERG loss in slow progressing patients: OD 5.4%, (95%CI: 1.1-9.6% N=13 pz, Adj R2 0,78); OS 11,4% (95%CI: 8.4-13.6% N=13 pz, Adj R2 0,88). In both fast and slow progressing CRD patients OD vs OS rates are not significantly different (Wilcoxon matched-pairs signed rank test of individual fits: Fast progressors P=0,8; Slow progressors P=0,31).

Conclusions: Baseline values of BCVA and fERG, as well as progression modality and rates of fERG loss show high inter-eye correlation in CRD patients. These data support the design of clinical trials involving unilateral treatment with the use of the fellow eye as internal control. 1Galli-Resta, L., M. Piccardi, L. Ziccardi, et al., Invest Ophthalmol Vis Sci 2013; 54(10): 6560-9

Keywords: 461 clinical (human) or epidemiologic studies: natural history • 494 degenerations/dystrophies • 509 electroretinography: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×